NeuroBioGen Lab-Memory Clinic, IRCCS "S. Giovanni di Dio-FBF", Brescia, Italy.
Eur J Neurol. 2010 Jan;17(1):143-6. doi: 10.1111/j.1468-1331.2009.02767.x. Epub 2009 Aug 5.
Frontotemporal lobar degeneration (FTLD) is a common cause of early-onset dementia. Given the role of cystatin C in brain neurodegeneration and neuroregeneration, the aim of this study was to determine whether the cystatin C gene (CST3) was genetically associated with FTLD.
Hundred and eighty-six FTLD patients and 457 controls underwent CST3 analysis by PCR and KspI enzyme digestion.
In FTLD patients negative for the presence of PGRN mutations, we found an over-representation of the CST3 haplotype B [odds ratio (OR = 1.619, P = 0.002)] and of AB/BB genotypes (OR = 1.704, P = 0.008) in FTLD patients.
The present study indicated the CST3 B haplotype as a putative risk factor for FTLD in PGRN mutations negative patients. The reduced level of cystatin C, previously associated with the B haplotype, might represent the molecular factor responsible for the increased risk. Long-term depletion of neurotrophic factors, such as cystatin C and progranulin proteins, seem to be a common theme in FTLD: boosting the expression of such proteins might be a promising therapeutic strategy for FTLD.
额颞叶变性(FTLD)是早发性痴呆的常见病因。鉴于半胱氨酸蛋白酶抑制剂 C(cystatin C)在脑神经退行性变和神经再生中的作用,本研究旨在确定胱抑素 C 基因(CST3)是否与 FTLD 存在遗传关联。
186 例 FTLD 患者和 457 例对照者接受 CST3 的 PCR 和 KspI 酶切分析。
在未发现 PGRN 突变的 FTLD 患者中,我们发现 CST3 单倍型 B 的出现频率过高[比值比(OR)=1.619,P=0.002],AB/BB 基因型的出现频率也过高(OR=1.704,P=0.008)。
本研究表明,CST3 B 单倍型可能是 PGRN 突变阴性患者发生 FTLD 的一个潜在危险因素。先前与 B 单倍型相关的胱抑素 C 水平降低,可能是导致风险增加的分子因素。神经保护因子(如胱抑素 C 和颗粒蛋白)的长期耗竭似乎是 FTLD 的一个共同主题:增加这些蛋白的表达可能是治疗 FTLD 的一种有前途的策略。